A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : IC / intracoronary

[Related PubMed/MEDLINE]
Total Number of Papers: 254
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   IC  (>> Co-occurring Abbreviation)
Long Form:   intracoronary
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes inWomen. CAD, CI, CR, HR, HR, MACE, WISE
2019 Intracoronary or intravenous abciximab after aspiration thrombectomy in patients with STEMI undergoing primary percutaneous coronary intervention. MBG, PCI, STEMI
2019 The effect of pegylated granulocyte colony-stimulating factor on collateral function and myocardial ischaemia in chronic coronary artery disease: A randomized controlled trial. CAD, CFI
2019 The Spontaneous Coronary Slow-Flow Phenomenon: Reversal by Intracoronary Nicardipine. CAD, CSF, TFC
2018 A Randomized Double-Blind Placebo-Controlled Study Comparing Intracoronary Versus Intravenous Abciximab in Patients With ST-Elevation Myocardial Infarction Undergoing Transradial Rescue Percutaneous Coronary Intervention After Failed Thrombolysis. CMR, PCI
2018 Comparison of regadenoson and nitroprusside to adenosine for measurement of fractional flow reserve: A systematic review and meta-analysis. FFR
2018 Intracoronary Glycoprotein IIb/IIIa Inhibitors Improve Short-Term Mortality and Reinfarction in East Asian Patients with ST-Segment Elevation Myocardial Infarction after Thrombus Aspiration: A Meta-Analysis. CI, GPIs, LVEF, MACE, OR, PCI, STEMI, STR, TA, TIMI
2018 Intracoronary high-dose bolus tirofiban administration during complex coronary interventions: A United States-based case series. ACS, GPIs, HDB
2018 Matrix Metalloproteinase-2 Impairs Homing of Intracoronary Delivered Mesenchymal Stem Cells in a Porcine Reperfused Myocardial Infarction: Comparison With Intramyocardial Cell Delivery. AMF, FGF-2, GFP, LVEF, MI, MMP-2, MSCs
10  2018 Perforated balloon technique: A simple and handy technique to combat no-reflow phenomenon in coronary system. ACS, PBT, PCI
11  2018 Simplifying the assessment of coronary artery stenosis by enhancing instantaneous wave free ratio. AUC, CAS, FFR, iFR, ROC
12  2017 An exploratory randomized control study of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with ischaemic cardiomyopathy: the REGENERATE-IHD clinical trial. BMCs, G-CSF, IM
13  2017 Cold Pressor Stress Cardiac Magnetic Resonance Myocardial Flow Reserve Is Not Useful for Detection of Coronary Endothelial Dysfunction in Women with Signs and Symptoms of Ischemia and No Obstructive CAD. CMD, CMRI, CPT, MPRI
14  2017 Comparison of Intracoronary and Intravenous Ultrasound-targeted Microbubble Destruction-mediated Ang1 Gene Transfection on Left Ventricular Remodeling in Canines With Acute Myocardial Infarction. Ang-1, IC-UTMD, IC-UTMD-Ang1, IV-UTMD, IV-UTMD-Ang1, MI
15  2017 Efficacy and safety of intracoronary verapamil versus sodium nitroprusside for the prevention of microvascular obstruction during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. MVO, PPCI, SNP
16  2017 Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. CDCs, CMI, IM, IS, LVEF, MI, MRI
17  2017 Impact of additional intracoronary nicorandil administration during fractional flow reserve measurement with intravenous adenosine 5'-triphosphate infusion. ATP, FFR, NIC
18  2017 Improvement of Local Cell Delivery Using Helix Transendocardial Delivery Catheter in a Porcine Heart. ---
19  2017 Intracoronary adenosine-induced ventricular arrhythmias during fractional flow reserve (FFR) measurement: case series and literature review. FFR
20  2017 Intralesional versus intracoronary administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention in patients with acute coronary syndromes: A meta-analysis of randomized controlled trials. ACS, CIs, cTFC, GPIs, IL, MACEs, OR, TIMI, WMD
21  2017 Meta-Analysis of Head-to-Head Comparison of Intracoronary Versus Intravenous Adenosine for the Assessment of Fractional Flow Reserve. CI, FFR
22  2017 Meta-Analysis of Randomized Trials of Intracoronary Versus Intravenous Glycoprotein IIb/IIIa Inhibitors in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. CI, MACE, RR
23  2017 Non-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury. CSC, IM
24  2017 Safety of intracoronary provocative testing for the diagnosis of coronary artery spasm. ACh, ERGO
25  2017 Temporal dissociation between the minimal distal-to-aortic pressure ratio and peak hyperemia during intravenous adenosine infusion. ---
26  2016 Appropriate bolus administration of glycoprotein IIb/IIIa inhibitors for patients with acute coronary syndromes undergoing percutaneous coronary intervention: intracoronary or intravenous? A comprehensive and updated meta-analysis and systematic review. GP, HF, LVEF, re-MI, TVR
27  2016 Comparison between the Outcomes of Intracoronary and Intravenous Administration of Eptifibatide during Primary Percutaneous Coronary Intervention in Patients with Acute ST-Elevation Myocardial Infarction. cTFC, LVEF, MACEs, PPCI, STEMI, TIMI, TPG, TVR
28  2016 Comparison of 1-year Major Adverse Cardiac Events in Patients Undergoing Primary Percutaneous Coronary Intervention Receiving Intracoronary Bolus Only Versus Intracoronary Bolus Plus Infusion of Glycoprotein IIb/IIIa Inhibitors. PCI
29  2016 Comparison of fractional flow reserve measurements using intracoronary adenosine versus intracoronary sodium nitroprusside infusions in moderately stenotic coronary artery lesions. FFR
30  2016 Efficacy and Safety of Local Intracoronary Drug Delivery in Treatment of No-Reflow Phenomenon: A Pilot Study. MACEs, PCI, TIMI
31  2016 Efficacy of coronary fractional flow reserve using contrast medium compared to adenosine. CMR, FFR
32  2016 Impaired coronary artery distensibility is an endothelium-dependent process and is associated with vulnerable plaque composition. ACh, CAD, CDI, CFR, CSA, IVUS
33  2016 Intracoronary Eptifibatide During Primary Percutaneous Coronary Intervention in Early Versus Late Presenters with ST Segment Elevation Myocardial Infarction: A Randomized Trial. cTFC, MBG, PPCI, STEMI, STR
34  2016 Intracoronary imaging of coronary atherosclerosis: validation for diagnosis, prognosis and treatment. ---
35  2016 Intracoronary Poloxamer 188 Prevents Reperfusion Injury in a Porcine Model of ST-Segment Elevation Myocardial Infarction. PEG, STEMI
36  2016 Safety and efficacy of intracoronary nicorandil as hyperaemic agent for invasive physiological assessment: a patient-level pooled analysis. BP, CA, HR
37  2016 Spontaneous multi-focal coronary artery spasm: a case report. PCI
38  2016 Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial. CMR, LV, MVO, PPCI, SNP, STEMI
39  2016 Ventricular fibrillation with intracoronary adenosine during fractional flow reserve assessment. ECG, FFR, NSTEMI, VF
40  2015 Bone Marrow-Derived Mesenchymal Stem Cells Have Innate Procoagulant Activity and Cause Microvascular Obstruction Following Intracoronary Delivery: Amelioration by Antithrombin Therapy. AMI, LV, MSCs, TF
41  2015 Coronary artery wall shear stress is associated with endothelial dysfunction and expansive arterial remodelling in patients with coronary artery disease. EI, IVUS, PAV, RI, SLV, WSS
42  2015 Efficacy and Safety of Intracoronary versus Intravenous Administration of Tirofiban during Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials. ACS, LVEF, MACE, PCI, RCTs, TIMI, TMP grade 3, TVR
43  2015 Efficacy of Adenosine in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A PRISMA-Compliant Meta-Analysis. AMI, CI, HF, LVEF, MBG, MDs, PCI, RRs, STR, TIMI
44  2015 Efficiencies of intracoronary sodium nitroprusside on fractional flow reserve measurement. AD, FFR, SNP
45  2015 Intracoronary Adenosine: Dose-Response Relationship With Hyperemia. LCAs, RCAs
46  2015 Long-term safety and feasibility of three-vessel multimodality intravascular imaging in patients with ST-elevation myocardial infarction: the IBIS-4 (integrated biomarker and imaging study) substudy. IVUS, MACE, MI, OCT, STEMI
47  2015 Lymphocyte subpopulations in myocardial infarction: a comparison between peripheral and intracoronary blood. PB
48  2015 Randomized evaluation of intralesion versus intracoronary abciximab and aspiration thrombectomy in patients with ST-elevation myocardial infarction: The COCTAIL II trial. AT, IL, PCI, STEMI, TIMI
49  2015 Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial. BMCs, DCM, G-CSF, LV, LVEF, NYHA
50  2015 Variability of fractional flow reserve according to the methods of hyperemia induction. ATP, FFR
51  2014 Comparison of the novel vasodilator uridine triphosphate and adenosine for the measurement of fractional flow reserve. FFR, UTP
52  2014 Complications of intracoronary abciximab bolus-only versus standard protocol during percutaneous coronary intervention in acute coronary syndrome. PPCI
53  2014 Effects of intracoronary sodium nitroprusside compared with adenosine on fractional flow reserve measurement. AD, AVB, FFR, SNP
54  2014 Efficacy of combination treatment with intracoronary abciximab and aspiration thrombectomy on myocardial perfusion in patients with ST-segment elevation myocardial infarction undergoing primary coronary stenting. AT, IMR, MVO, PCI, STEMI
55  2014 Intracoronary and retrograde coronary venous myocardial delivery of adipose-derived stem cells in swine infarction lead to transient myocardial trapping with predominant pulmonary redistribution. AMI, ASCs, CFR, IMR, LAD, RCV
56  2014 Intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements. ADN, FFR, IVADN
57  2014 Left main coronary arterial endothelial function and heterogenous segmental epicardial vasomotor reactivity in vivo: novel insights with intravascular ultrasonography. LA, LMCA, PAV
58  2014 ST elevation after intracoronary administration of Papaverine for fractional flow reserve estimation. FFR
59  2014 The effect of acute simvastatin administration on the severity of arrhythmias resulting from ischaemia and reperfusion in the canine: Is there a role for nitric oxide? NO, VPBs, VT
60  2013 Comparison of efficacy and safety of intracoronary sodium nitroprusside and intravenous adenosine for assessing fractional flow reserve. FFR, IVA, NTP
61  2013 Effects of coronary sinus occlusion on myocardial ischaemia in humans: role of coronary collateral function. CFI, ICSO, Pao
62  2013 Fractional flow reserve: intracoronary versus intravenous adenosine induced maximal coronary hyperemia. FFR
63  2013 Impact of selective infarct-related artery infusion of tirofiban on myocardial reperfusion and bleeding complications in patients with acute myocardial infarction: the SUIT-AMI trial. GPI, sIRA, STEMI, TIMI
64  2013 Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: the Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI) trial. mLAD
65  2013 Intracoronary abciximab reduces death and major adverse cardiovascular events in acute coronary syndromes: a meta-analysis of clinical trials. GPI
66  2013 Intracoronary adenosine to prevent myonecrosis in patients with stable angina undergoing percutaneous interventions: a double-blinded randomized controlled trial. CK-MB, cTnI, PCI
67  2013 Intracoronary fixed dose of nitroprusside via thrombus aspiration catheter for the prevention of the no-reflow phenomenon following primary percutaneous coronary intervention in acute myocardial infarction. CK, IRA, LVEF, MACEs, NR, NTP, PCI, STEMI, STR, TIMI, TMPG
68  2013 Intracoronary Reopro during Percutaneous Coronary Intervention in Acute and Stable Patient can Influence Stent Thrombosis Formation (IRPASST) Study. BMS, DES, ISR, MACE, PCI, ST, TRV, TVR
69  2013 Intracoronary versus intravenous administration of abciximab in patients with acute coronary syndrome: a meta-analysis. ACS, CI, i.v, RR
70  2013 Intravenous versus intracoronary bolus of glycoprotein IIb/IIIa inhibitor administration during primary percutaneous coronary intervention on long-term left ventricular systolic and diastolic function. GP, LV, PCI, STEMI
71  2013 Meta-analysis of randomized controlled trials on the efficacy and safety of intracoronary administration of tirofiban for no-reflow phenomenon. MACE, NR, PCI, TIMI
72  2013 Safety and efficacy of a novel hyperaemic agent, intracoronary nicorandil, for invasive physiological assessments in the cardiac catheterization laboratory. FFR, i.v
73  2013 The effect of rigorous study design in the research of autologous bone marrow-derived mononuclear cell transfer in patients with acute myocardial infarction. AMI, BMSCs, LVEF, PCI
74  2012 A comparison of intracoronary with intravenous glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention in patients with acute coronary syndrome: a meta-analysis of randomized controlled trials. ACS, GPIs, LVEF, MACEs, PCI, TIMI, TMPG, TVR
75  2012 Appropriate timing of nitroglycerin prior to intravascular ultrasound. AoP, EEMa, EEMd, IVUS, LA, LD, NTG, sec
76  2012 Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials. PCI, STEMI
77  2012 Clinical efficacy and safety of intracoronary vs. intravenous abciximab administration in STEMI patients undergoing primary percutaneous coronary intervention: a meta-analysis of randomized trials. CI, PPCI, STEMI, TVR
78  2012 Concomitant intravenous nitroglycerin with intracoronary delivery of AAV1.SERCA2a enhances gene transfer in porcine hearts. LV, mRNA, NTG
79  2012 Coronary beta2-adrenoreceptors mediate endothelium-dependent vasoreactivity in humans: novel insights from an in vivo intravascular ultrasound study. IVUS, L-NMMA, PAV
80  2012 Granulation tissue is altered after intramyocardial and intracoronary bone marrow-derived cell transfer for experimental acute myocardial infarction. AMI, BMMC, EF, IM
81  2012 Intracoronary use of GP IIb/IIIa inhibitors in percutaneous coronary interventions. GP, PCI
82  2012 Ischemia-reperfusion increases transfection efficiency of intracoronary adenovirus type 5 in pig heart in situ. TE
83  2012 Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion. sTnI
84  2012 Maximal hyperemia in the assessment of fractional flow reserve: intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: the NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study. ADN, FFR, i.v, IVADN, NTP
85  2012 Meta-analysis of prospective randomized controlled trials comparing intracoronary versus intravenous abciximab in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. PPCI
86  2012 Transendocardial cell injection is not superior to intracoronary infusion in a porcine model of ischaemic cardiomyopathy: a study on delivery efficiency. MSC, TE
87  2012 Updated evidence on intracoronary abciximab in ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized clinical trials. CI, OR, RCTs, re-MI, STEMI, TVR
88  2012 Vasomotor response to different endothelium-dependent vasodilators in an animal model. ---
89  2011 Aborted myocardial infarction in intracoronary compared with standard intravenous abciximab administration in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction. MACEs, MRI, PCI, STEMI
90  2011 Biodistribution of bone marrow mononuclear cells in chronic chagasic cardiomyopathy after intracoronary injection. BM, ChC, MNC
91  2011 Intracoronary compared to intravenous abciximab in patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention reduces mortality, target vessel revascularization and reinfarction after 1 year. MI, PPCI, STEMI, TVR, TVR
92  2011 Intracoronary compared to intravenous bolus abciximab during primary percutaneous coronary intervention in ST-segment Elevation Myocardial Infarction (STEMI) patients reduces 30-day mortality and target vessel revascularization: a randomized trial. MI, PPCI, STEMI, TVR
93  2011 Intracoronary delivery of eptifibatide with the ClearWay RX infusion catheter. RO
94  2011 Intracoronary versus intravenous abciximab administration in STEMI patients: overview of current status and open questions. STEMI
95  2011 Intracoronary versus intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: 6-month effects on infarct size and left ventricular function. The randomised Leipzig Immediate PercutaneouS Coronary Intervention Abciximab i.v. versus i.c. in ST-Elevation Myocardial Infarction Trial (LIPSIAbciximab-STEMI). MACE, PCI, STEMI
96  2011 Management of acute cardiac failure by intracoronary administration of levosimendan. ---
97  2011 Meta-analysis of randomized controlled trials of intracoronary versus intravenous administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention for acute coronary syndrome. CI, GPIs, PCI, RCTs, RR
98  2011 Pharmacoinvasive therapy for acute myocardial infarction. PCI, STEMI
99  2010 Comparison of intracoronary versus intravenous administration of tirofiban in primary percutaneous coronary intervention. CPK, MACE, PCI, STEMI
100  2010 Improved clinical outcomes with intracoronary compared to intravenous abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a systematic review and meta-analysis. ACS, CI, OR, PCI, STEMI